Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. / de Sa, João Carlos Correia; Airas, Laura; Bartholome, Emmanuel; Grigoriadis, Nikolaos; Mattle, Heinrich; Oreja-Guevara, Celia; O'Riordan, Jonathan; Sellebjerg, Finn; Stankoff, Bruno; Vass, Karl; Walczak, Agata; Wiendl, Heinz; Kieseier, Bernd C.

I: Therapeutic Advances in Neurological Disorders, Bind 4, Nr. 3, 2011, s. 139-68.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

de Sa, JCC, Airas, L, Bartholome, E, Grigoriadis, N, Mattle, H, Oreja-Guevara, C, O'Riordan, J, Sellebjerg, F, Stankoff, B, Vass, K, Walczak, A, Wiendl, H & Kieseier, BC 2011, 'Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice', Therapeutic Advances in Neurological Disorders, bind 4, nr. 3, s. 139-68. https://doi.org/10.1177/1756285611403646

APA

de Sa, J. C. C., Airas, L., Bartholome, E., Grigoriadis, N., Mattle, H., Oreja-Guevara, C., O'Riordan, J., Sellebjerg, F., Stankoff, B., Vass, K., Walczak, A., Wiendl, H., & Kieseier, B. C. (2011). Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Therapeutic Advances in Neurological Disorders, 4(3), 139-68. https://doi.org/10.1177/1756285611403646

Vancouver

de Sa JCC, Airas L, Bartholome E, Grigoriadis N, Mattle H, Oreja-Guevara C o.a. Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Therapeutic Advances in Neurological Disorders. 2011;4(3):139-68. https://doi.org/10.1177/1756285611403646

Author

de Sa, João Carlos Correia ; Airas, Laura ; Bartholome, Emmanuel ; Grigoriadis, Nikolaos ; Mattle, Heinrich ; Oreja-Guevara, Celia ; O'Riordan, Jonathan ; Sellebjerg, Finn ; Stankoff, Bruno ; Vass, Karl ; Walczak, Agata ; Wiendl, Heinz ; Kieseier, Bernd C. / Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. I: Therapeutic Advances in Neurological Disorders. 2011 ; Bind 4, Nr. 3. s. 139-68.

Bibtex

@article{8be0bcef62be42de9d0f1df3985c5298,
title = "Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice",
abstract = "As more investigations into factors affecting the quality of life of patients with multiple sclerosis (MS) are undertaken, it is becoming increasingly apparent that certain comorbidities and associated symptoms commonly found in these patients differ in incidence, pathophysiology and other factors compared with the general population. Many of these MS-related symptoms are frequently ignored in assessments of disease status and are often not considered to be associated with the disease. Research into how such comorbidities and symptoms can be diagnosed and treated within the MS population is lacking. This information gap adds further complexity to disease management and represents an unmet need in MS, particularly as early recognition and treatment of these conditions can improve patient outcomes. In this manuscript, we sought to review the literature on the comorbidities and symptoms of MS and to summarize the evidence for treatments that have been or may be used to alleviate them.",
author = "{de Sa}, {Jo{\~a}o Carlos Correia} and Laura Airas and Emmanuel Bartholome and Nikolaos Grigoriadis and Heinrich Mattle and Celia Oreja-Guevara and Jonathan O'Riordan and Finn Sellebjerg and Bruno Stankoff and Karl Vass and Agata Walczak and Heinz Wiendl and Kieseier, {Bernd C}",
year = "2011",
doi = "http://dx.doi.org/10.1177/1756285611403646",
language = "English",
volume = "4",
pages = "139--68",
journal = "Therapeutic Advances in Neurological Disorders",
issn = "1756-2856",
publisher = "SAGE Publications",
number = "3",

}

RIS

TY - JOUR

T1 - Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice

AU - de Sa, João Carlos Correia

AU - Airas, Laura

AU - Bartholome, Emmanuel

AU - Grigoriadis, Nikolaos

AU - Mattle, Heinrich

AU - Oreja-Guevara, Celia

AU - O'Riordan, Jonathan

AU - Sellebjerg, Finn

AU - Stankoff, Bruno

AU - Vass, Karl

AU - Walczak, Agata

AU - Wiendl, Heinz

AU - Kieseier, Bernd C

PY - 2011

Y1 - 2011

N2 - As more investigations into factors affecting the quality of life of patients with multiple sclerosis (MS) are undertaken, it is becoming increasingly apparent that certain comorbidities and associated symptoms commonly found in these patients differ in incidence, pathophysiology and other factors compared with the general population. Many of these MS-related symptoms are frequently ignored in assessments of disease status and are often not considered to be associated with the disease. Research into how such comorbidities and symptoms can be diagnosed and treated within the MS population is lacking. This information gap adds further complexity to disease management and represents an unmet need in MS, particularly as early recognition and treatment of these conditions can improve patient outcomes. In this manuscript, we sought to review the literature on the comorbidities and symptoms of MS and to summarize the evidence for treatments that have been or may be used to alleviate them.

AB - As more investigations into factors affecting the quality of life of patients with multiple sclerosis (MS) are undertaken, it is becoming increasingly apparent that certain comorbidities and associated symptoms commonly found in these patients differ in incidence, pathophysiology and other factors compared with the general population. Many of these MS-related symptoms are frequently ignored in assessments of disease status and are often not considered to be associated with the disease. Research into how such comorbidities and symptoms can be diagnosed and treated within the MS population is lacking. This information gap adds further complexity to disease management and represents an unmet need in MS, particularly as early recognition and treatment of these conditions can improve patient outcomes. In this manuscript, we sought to review the literature on the comorbidities and symptoms of MS and to summarize the evidence for treatments that have been or may be used to alleviate them.

U2 - http://dx.doi.org/10.1177/1756285611403646

DO - http://dx.doi.org/10.1177/1756285611403646

M3 - Journal article

VL - 4

SP - 139

EP - 168

JO - Therapeutic Advances in Neurological Disorders

JF - Therapeutic Advances in Neurological Disorders

SN - 1756-2856

IS - 3

ER -

ID: 40194202